Jan Willem Alffenaar

Filter

2021
Anti-Tuberculosis Drugs and Adverse Events
Kim, H. Y., Cho, J. G., Akkerman, O. W., Padanilam, X., Seaworth, B. & Alffenaar, J. W. C., 1-jan.-2021, Essential Tuberculosis. Springer International Publishing AG, blz. 121-129 9 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand
45 Downloads (Pure)
2018
Monitoring during and after treatment
Akkerman, O., Alffenaar, J.-W. & Bothamley, G., 1-dec.-2018, Tubercolosis: ERS monograph. Gozzard, R. (uitgave). Sheffield: European Respiratory Society, blz. 308-325 17 blz. (ERS Monograph).
Onderzoeksoutput › Professional
4 Citaten (Scopus)
Monitoring during and after tuberculosis treatment.
Alffenaar, J.-W., Akkerman, O. & Bothamley, G., 1-dec.-2018, Tuberculosis. blz. 308-326 19 blz. (ERS Monograph).
Onderzoeksoutput › Academic › peer review
2017
Antifungal PK/PD in the critically Ill
Brüggemann, R. J. M., de Lange, D. W. & Jan-Willem, C. A., 18-sep.-2017, Antibiotic Pharmacokinetic/Pharmacodynamic Considerations in the Critically Ill. Springer Singapore, blz. 213-238 26 blz.
Onderzoeksoutput › Academic › peer review

Open Access
Bestand
1 Citaat (Scopus)

172 Downloads (Pure)

Onderzoeksoutput